Research Papers:

Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T

Jonathan Klein, Wilfred W. Lam, Gregory J. Czarnota and Greg J. Stanisz _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:31490-31501. https://doi.org/10.18632/oncotarget.25844

Metrics: PDF 607 views  |   HTML 1026 views  |   ?  


Jonathan Klein1,2,3,4, Wilfred W. Lam1, Gregory J. Czarnota1,2,3,4 and Greg J. Stanisz1,2,5

1Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada

2Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada

3Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada

4Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

5Department of Neurosurgery and Pediatric Neurosurgery, Medical University of Lublin, Lublin, Poland

Correspondence to:

Greg J. Stanisz, email: stanisz@sri.utoronto.ca

Keywords: CEST; MRI; breast cancer; cell death; response monitoring

Received: March 14, 2018     Accepted: July 12, 2018     Published: July 31, 2018


Purpose: Detecting cell death and predicting tumor response early in a course of chemotherapy could help optimize treatment regimens and improve clinical outcomes. Chemical exchange saturation transfer (CEST) MRI was investigated in vivo to study properties that may be able to detect cancer death.

Results: Using a magnetization transfer ratio (MTR) cutoff of 0.12 at 1.8 ppm was able to differentiate between viable tumor and cell death regions. Comparison of MTR values at this frequency showed significant differences (p < 0.0001) between viable tumor and cell death regions, matching patterns seen on histology. Using this cutoff, the mean increase in cell death index (± standard error of the mean) after chemotherapy was 4 ± 4%, 10% ± 7%, 10 ± 8%, and 4 ± 9% at 4, 8, 12, and 24 h, respectively.

Conclusions: CEST MRI can detect cell death in MDA-231 xenografts but further work is needed to characterize the clinical applications of this finding. Maximum response to chemotherapy occurred at 8–12 h after chemotherapy injection in this in vivo tumor model.

Materials and Methods: Breast cancer xenografts (MDA-MB-231) were scanned using 7 T MRI before and after chemotherapy. As a measure of CEST effect at 0.5 μT saturation amplitude, MTR values at frequency offsets of 1.8 and −3.3 ppm were evaluated. CEST signals after chemotherapy treatment were compared to cell-death histopathology of tumors.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 25844